Ginkgo Results Presentation Deck
These transactions complement each other, opening new market
opportunities and improving our platform capabilities for our customers
End Market
Asset purchase deepens ag biologicals vertical expertise
• Leading "translational research" capabilities enhance our
offering and will allow us to make these capabilities broadly
available to the ag biologicals market
Collaboration provides significant revenue opportunity
• Ginkgo's largest ever cell programming contract (in terms of
R&D service fees)
• Ability to work with new customers on the platform
B
A
BAYER
R
JOYN
BIO
z
zymergen
✓ Expanded TAM
✔ New capabilities
Broad platform
improvements
Automation and software built with flexibility in mind complements Ginkgo's strengths
• Believe we can quickly deploy Zymergen's scalable architecture alongside Ginkgo's own automation capabilities
• Talent fits within and is expected to accelerate scaling plans
Data organization and analysis tools can help us take advantage of our codebase assets
General Purpose Capabilities
18
Property of Ginkgo Bioworks
Q2 2022 UPDATE & BUSINESS REVIEWView entire presentation